Florida Venture Forum Selects 3 Orlando Presenting Startups For The 2019 Early Stage Capital Conference

The Florida Venture Forum has selected 3 Orlando startups to present at its 12th annual Florida Early Stage Capital Conference, being held at Omni ChampionsGate in Orlando on May 9th-May 10th. The conference also will feature the 9th annual 2019 Statewide Collegiate Startup Competition, attracting the “best of the best” competitors, representing Florida’s major colleges and universities.

We had a record number of applications this year and our selection committee did an outstanding job of choosing 20 of Florida’s most promising early and seed stage companies,” said Tim Cartwright, partner & co-founder, Fifth Avenue Family Office, chair of the conference selection committee and a board member of the Florida Venture Forum.  “For those investors that are looking for the next Chewy or Magic Leap, this conference is a must attend event.

In addition to company presentations and other programming, the conference will feature a total of $100,000 in cash awards distributed between early stage and seed stage companies, provided by Space Florida. To date, past early stage presenters have attracted more than $100 million in funding.

The 3 selected Orlando presenting companies are:

Capacitech (www.capacitechenergy.com) is commercializing patent protected, advanced energy storage technology from University of Central Florida. Capacitech sells 100ft spools of series-connected and customizable Cable-Based Capacitors (CBCs) to distributors selling to OEMs and end users. The CBC will be used to complement batteries in the solar & IT markets to reduce their cost of ownership. It can also help miniaturize electronics by replacing large, traditional capacitors on circuits.

eCare21,Inc. (www.ecare21.com) offers a secure, patient-centered mobile Health IT platform that enables virtual healthcare delivery in every setting across the continuum of care. The eCare21 platform features secure, networked technologies; a refined, flexible user experience, integrated advanced analytics, technical & workflow interoperability with legacy HIM systems, and the ability to adapt to a rapidly-evolving policy environment. The eCare21 mobile App enables proactive patient engagement & self-management and has been formally recognized as a leading Caregiving App in 2017 & 2018.

SegAna LLC (www.seganatech.com) is a medical device company that has developed a cloud-based software platform utilizing artificial Intelligence and a proprietary algorithm that measures changes in patient specific tissue elasticity for enhancing radiation treatment of cancer. The company’s patent pending state of the art technology enhances the treatment of cancer by providing the Radiation Oncologist, in any setting or location, with the ability to accurately define the margin of the tumor on the day of treatment and predict an abnormal treatment up to 3 days in the future. The Radiation Oncologist utilizes this information to develop a new patient treatment plan which will ultimately reduce radiation damage to the tissue surrounding the tumor and improve a patient’s outcome.